Moreover, one of the treatment strategies in hematopoietic malignancies currently being explored is release of leukemia or lymphoma cells from the stem cell niches they occupy - by blocking the SDF-1–CXCR4 axis [24,98,99] or by blocking other homing signals to render them more sensitive to chemotherapeutic agents. Here, CXCL12 is linked to lymphoma.